A trial of a ‘third generation’ anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has shown good results for relapsed or refractory B-Cell non-Hodgkin’s lymphomas, researchers have reported at the Annual Meeting of the American Society of H...
9 months ago
A new way to distinguish different subtypes of Hodgkin’s lymphoma using DNA from tumours circulating in blood has been reported by scientists at the American Society of Hematology (ASH) Annual Meeting.
Because malignant Hodgkin’s cells are diffi...
9 months ago
